Your browser doesn't support javascript.
loading
Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients With Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial.
Shao, Zhimin; Pang, Da; Yang, Hongjian; Li, Wei; Wang, Shusen; Cui, Shude; Liao, Ning; Wang, Yongsheng; Wang, Chuan; Chang, Yuan-Ching; Wang, Hweichung; Kang, Seok Yun; Seo, Jae Hong; Shen, Kunwei; Laohawiriyakamol, Suphawat; Jiang, Zefei; Li, Junjie; Zhou, Julian; Althaus, Betsy; Mao, Yixiang; Eng-Wong, Jennifer.
Afiliação
  • Shao Z; Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Pang D; Breast Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
  • Yang H; Breast Surgery, Zhejiang Cancer Hospital, Hangzhou, China.
  • Li W; Medicine-Oncology, The First Hospital of Jilin University, Changchun, China.
  • Wang S; Medicine-Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Cui S; Department of Breast Disease, Henan Cancer Hospital, Zhengzhou, China.
  • Liao N; Department of Breast Disease, Guangdong General Hospital, Guangzhou, China.
  • Wang Y; Breast Disease Center, Shandong Cancer Hospital, Jinan, China.
  • Wang C; Breast Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Chang YC; Department of General Surgery, Mackay Memorial Hospital, Taipei City, Taiwan.
  • Wang H; Department of Surgery, China Medical University Hospital, Taichung City, Taiwan.
  • Kang SY; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Seo JH; Division of Oncology/Hematology, Department of Internal Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.
  • Shen K; Breast Disease Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Laohawiriyakamol S; Department of Surgery, Songklanagarind Hospital, Songkhla, Thailand.
  • Jiang Z; Medicine-Oncology, The Affiliated Hospital of Military Medical Sciences (The 307th Hospital of Chinese People's Liberation Army), Beijing, China.
  • Li J; Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Zhou J; Biometrics, Roche Product Development, Shanghai, China.
  • Althaus B; Product Development Oncology, Genentech, Inc, South San Francisco, California.
  • Mao Y; Roche Product Development, Shanghai, China.
  • Eng-Wong J; now at Oncology Clinical Research, Merck Sharp & Dohme China, Shanghai, China.
JAMA Oncol ; 6(3): e193692, 2020 03 01.
Article em En | MEDLINE | ID: mdl-31647503
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Anticorpos Monoclonais Humanizados / Trastuzumab / Docetaxel Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Anticorpos Monoclonais Humanizados / Trastuzumab / Docetaxel Idioma: En Ano de publicação: 2020 Tipo de documento: Article